Dashboard
Manage Tickers

TECH BIO-TECHNE Corp

Nasdaq bio-techne.com


$ 66.06 $ 2.27 (3.56 %)    

Thursday, 23-Oct-2025 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 611.68 $ 5.09 (0.84 %)
DIA $ 467.15 $ 1.51 (0.32 %)
SPY $ 672.21 $ 3.96 (0.59 %)
TLT $ 91.36 $ -0.63 (-0.68 %)
GLD $ 378.50 $ 1.51 (0.4 %)
$ 66.06
$ 64.00
$ 65.09 x 1
$ 68.66 x 5
$ 63.29 - $ 66.40
$ 45.87 - $ 80.37
2,368,508
na
10.28B
$ 1.26
$ 139.99
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-22-2025 06-30-2025 10-K
2 05-08-2025 03-31-2025 10-Q
3 02-06-2025 12-31-2024 10-Q
4 11-05-2024 09-30-2024 10-Q
5 08-22-2024 06-30-2024 10-K
6 05-06-2024 03-31-2024 10-Q
7 02-07-2024 12-31-2023 10-Q
8 11-07-2023 09-30-2023 10-Q
9 08-23-2023 06-30-2023 10-K
10 05-08-2023 03-31-2023 10-Q
11 02-07-2023 12-31-2022 10-Q
12 11-07-2022 09-30-2022 10-Q
13 08-24-2022 06-30-2022 10-K
14 05-09-2022 03-31-2022 10-Q
15 02-07-2022 12-31-2021 10-Q
16 11-08-2021 09-30-2021 10-Q
17 08-25-2021 06-30-2021 10-K
18 05-07-2021 03-31-2021 10-Q
19 02-08-2021 12-31-2020 10-Q
20 11-09-2020 09-30-2020 10-Q
21 08-26-2020 06-30-2020 10-K
22 05-11-2020 03-31-2020 10-Q
23 02-06-2020 12-31-2019 10-Q
24 11-06-2019 09-30-2019 10-Q
25 08-28-2019 06-30-2019 10-K
26 05-07-2019 03-31-2019 10-Q
27 02-07-2019 12-31-2018 10-Q
28 11-07-2018 09-30-2018 10-Q
29 08-27-2018 06-30-2018 10-K
30 05-09-2018 03-31-2018 10-Q
31 02-08-2018 12-31-2017 10-Q
32 11-09-2017 09-30-2017 10-Q
33 09-07-2017 06-30-2017 10-K
34 05-10-2017 03-31-2017 10-Q
35 02-09-2017 12-31-2016 10-Q
36 11-09-2016 09-30-2016 10-Q
37 08-29-2016 06-30-2016 10-K
38 05-10-2016 03-31-2016 10-Q
39 02-09-2016 12-31-2015 10-Q
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

scaleready-and-partners-provide-grant-funding-to-support-cancer-therapy-research-at-childrens-national
ScaleReady and Partners Provide Grant Fund...
10/23/2025 11:14:39

ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ:TECH) and CellReady, announced four...

td-cowen-maintains-buy-on-bio-techne-raises-price-target-to-70
TD Cowen Maintains Buy on Bio-Techne, Rais...
10/14/2025 12:58:54

TD Cowen analyst Kyle Boucher maintains Bio-Techne (NASDAQ:TECH) with a Buy and raises the price target from $65 to $70.

bio-techne-and-oxford-nanopore-expand-collaboration-through-2032-granting-bio-techne-broader-rights-to-develop-genetics-products-beyond-amplidex-nanopore-carrier-plus-kit
Bio-Techne And Oxford Nanopore Expand Coll...
10/09/2025 11:25:36

bio-techne-oxford-nanopore-technologies-expand-agreement-to-develop-portfolio-of-genetics-products-beyond-amplidex-nanopore-carrier-plus-kit
Bio-Techne, Oxford Nanopore Technologies E...
10/09/2025 11:25:14

5-analysts-assess-bio-techne-what-you-need-to-know
5 Analysts Assess Bio-Techne: What You Nee...
10/07/2025 22:01:25

evercore-isi-group-maintains-outperform-on-bio-techne-raises-price-target-to-72
Evercore ISI Group Maintains Outperform on...
10/07/2025 17:58:04

Evercore ISI Group analyst Daniel Markowitz maintains Bio-Techne (NASDAQ:TECH) with a Outperform and raises the price target...

trump-pfizer-deal-pushes-health-care-stocks-to-best-rally-in-5-years
Trump-Pfizer Deal Pushes Health Care Stock...
10/01/2025 20:22:35

Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tari...

bio-techne-advances-spatial-biology-portfolio-for-rnascope-ish-technology-and-lunaphore-comet
Bio-Techne Advances Spatial Biology Portfo...
09/26/2025 10:31:58

RNAscope™ technology and the Lunaphore COMET™ enable simultaneous RNA and protein detection on the same tissue sectionTechnolog...

bio-techne-stock-upgraded-as-analyst-flags-attractive-entry-point
Bio-Techne Stock Upgraded As Analyst Flags...
09/03/2025 18:45:40

RBC Capital upgraded Bio-Techne, citing M&A confidence, margin gains, and growth potential after a sharp stock drop and ali...

rbc-capital-upgrades-bio-techne-to-outperform-raises-price-target-to-73
RBC Capital Upgrades Bio-Techne to Outperf...
09/03/2025 13:57:08

RBC Capital analyst Conor McNamara upgrades Bio-Techne (NASDAQ:TECH) from Sector Perform to Outperform and raises the price ...

6-analysts-have-this-to-say-about-bio-techne
6 Analysts Have This To Say About Bio-Techne
08/21/2025 14:02:06

citigroup-upgrades-bio-techne-to-buy-raises-price-target-to-70
Citigroup Upgrades Bio-Techne to Buy, Rais...
08/21/2025 12:45:00

Citigroup analyst Patrick Donnelly upgrades Bio-Techne (NASDAQ:TECH) from Neutral to Buy and raises the price target from $5...

rbc-capital-maintains-sector-perform-on-bio-techne-lowers-price-target-to-61
RBC Capital Maintains Sector Perform on Bi...
08/07/2025 14:44:38

RBC Capital analyst Conor McNamara maintains Bio-Techne (NASDAQ:TECH) with a Sector Perform and lowers the price target from...

during-conf-call-bio-techne-corp-exec-reportedly-says-co-anticipates-organic-growth-will-remain-in-a-low-single-digit-range-until-the-current-headwinds-begin-to-subside-customers-are-actually-behaving-more-conservative-than-even-the-worst-case-scenario
During Conf Call, Bio-Techne Corp Exec Rep...
08/06/2025 14:10:48

during-conf-call-bio-techne-corp-exec-reportedly-says-china-surprised-positively-increasing-low-double-digits-in-q4-as-the-region-returned-to-growth-ahead-of-anticipated-tariff-impact
During Conf Call, Bio-Techne Corp Exec Rep...
08/06/2025 13:32:14

during-conf-call-bio-techne-corp-exec-reportedly-says-cos-total-exposure-to-nih-funded-research-is-in-low-single-digits-below-cos-prior-estimates-of-5-to-6
During Conf Call, Bio-Techne Corp Exec Rep...
08/06/2025 13:28:02

bio-techne-announced-that-it-will-pay-a-dividend-of-008-per-share-for-the-quarter-ended-june-30-dividend-will-be-payable-august-29
Bio-techne Announced That It Will Pay A Di...
08/06/2025 10:39:31

bio-techne-q4-adj-eps-053-beats-050-estimate-sales-316964m-beat-316004m-estimate
Bio-Techne Q4 Adj. EPS $0.53 Beats $0.50 E...
08/06/2025 10:31:08

Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.53 per share which beat the analyst consensus estimate of $0.50 by 5...

Core News & Articles
Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

bio-techne-corporation-announces-agreement-where-mdxhealth-sa-will-acquire-its-exosome-diagnostics-inc-business-including-the-exodx-prostate-test-clia-certified-clinical-laboratory-and-related-assets-under-agreement-bio-techne-will-receive-5m-in-mdxh-stock
Bio-Techne Corporation Announces Agreement...
08/05/2025 20:59:22

Bio-Techne Corporation (NASDAQ:TECH) today announced an agreement where Mdxhealth SA will acquire its Exosome Diagnostics Inc. ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION